Later, ERG/SPINK1 immunohistochemistry analyses performed in different foci of prostate cancer samples revealed that ERG and SPINK1 overexpression were mutually exclusive in all tumor foci (Fontugne et al., 2016). This evidence concerns the gene SPINK1 and prostate cancer.